From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow
BioProcessing Journal · 2026-07-28 · 3
DOI: 10.12665/j152.carson ↗At a glance
Journal article in BioProcessing Journal, published online on 2026-07-28. Written by Keith L. Carson.
Abstract (original language)
As biologics continue to advance at a dizzying pace, I want to take this opportunity to outline what I see as the major successes, as well as the primary challenges facing the industry. First, the science of antibody production appears to be quite settled. Significant value can be gained by finding ways to limit production batches to volumes that can be accommodated by single-use bioreactor systems...
Cite
APA
Carson, K. L. (2026). From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow. BioProcessing Journal, 3. https://doi.org/10.12665/j152.carson
Vancouver
Carson KL. From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow. BioProcessing Journal. 2026:3. doi:10.12665/j152.carson
BibTeX
@article{Carson2026,
author = {Carson, Keith L.},
title = {From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow},
journal = {BioProcessing Journal},
year = {2026},
pages = {3},
doi = {10.12665/j152.carson}
}
EUVIMED